By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews today reported that it has cut its first-quarter net loss 30 percent, even though it had hardly any revenue for the period.

The Toronto-based molecular diagnostics firm brought in total revenues of just C$4,417 (US$4,298) for the three-month period ended March 31, compared to C$259,210 for the first quarter of 2009. The bulk of last year's revenues came from non-refundable license revenue, the firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.